Identifying key questions to advance research and practice in cancer survivorship follow-up care: a report from the ASPO Survivorship Interest Group.

摘要

Cancer survivorship encompasses the physical, psychosocial, and economic consequences of cancer, including issues related to health care and follow-up treatment, late effects of treatment, surveillance for recurrence of the primary, screening for second primary cancers, and quality of life. Almost two-thirds of individuals diagnosed with cancer are expected to survive for at least 5 years. For some cancers, such as breast and prostate, 5-year survival rates exceed 88% (1). There is concern that the increasing numbers of cancer survivors combined with greater cancer incidence (2) will result in an oncologic service challenge that the US health care system is ill-equipped to handle. The American Society of Clinical Oncology (ASCO) projects a medical oncologist shortage by 2020 that will necessitate a multifaceted strategy in order to meet future oncology and cancer follow-up care demands (3).